tirzepatide surpass cvot SURPASS-CVOT: better than dulagluti In patients with type 2

What CMS is planning to do Through the BALANCE Model, CMS plans to: Work with voluntary GLP-1 manufacturers to establish pricing and access terms Create a standardized pathway for participating Medicaid programs and Medicare plans to cover these medications Pair medication access with lifestyle and nutrition supports grounded in current scientific evidence Evaluate how the model affects access to care, health outcomes, costs and peoples experiences Key dates to know What we dont know yet Several important details have not been finalized, including: When beneficiaries will know whether their state Medicaid program or Medicare plan is participating What the enrollment process will look like The exact clinical criteria for individual eligibility to the programs What lifestyle and nutrition supports will be offered Whether lifestyle and nutrition supports will differ by drug manufacturer Because participation is voluntary for manufacturers and plans, we dont know how many people will participate in the programs An important first step Most people living with obesity who rely on Medicare or Medicaid face barriers to accessing obesity treatments

We provide a personalized framework that addresses the nutritional gaps often created by reduced caloric intake

While water itself doesnt go bad, it can become contaminated or change in quality based on storage conditions, exposure to air, or the container its in

The unique glucagon receptor component that drives liver fat reduction and potentially increased energy expenditure

Providers who proactively communicate about FDA guidance changes, explain how those changes affect their patients, and have contingency plans for supply disruptions earn trust that fair-weather providers lose when the regulatory landscape shifts

Is that different from when Manufacturers game patent rules, extending their exclusivity by making a slight change to the chemical formula for a patent about to expire to gain extra years of exclusivity, or implementing a pay for delay strategy, where potential competitors are bought off to delay competition Tell me what you think